Fig. 2.
Fig. 2. AML and L-ML mRNA expression profiles. / Representative Northern blots containing total cellular RNA (approximately 20 μg) prepared from control spleen or kidney. (A)IgHG leukemias. (B) IgHRleukemias. Separate blots were probed with myeloperoxidase (MPO), lysozyme M (LysM), CD19, PU1, Vpre-B1, Rag1, or glutathione peroxidase cDNA probes. Quantitation of the Northern blots is summarized in Table 3.

AML and L-ML mRNA expression profiles.

Representative Northern blots containing total cellular RNA (approximately 20 μg) prepared from control spleen or kidney. (A)IgHG leukemias. (B) IgHRleukemias. Separate blots were probed with myeloperoxidase (MPO), lysozyme M (LysM), CD19, PU1, Vpre-B1, Rag1, or glutathione peroxidase cDNA probes. Quantitation of the Northern blots is summarized in Table 3.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal